Induction of immunogenic cell death by anti-CD20 antibodies

被引：0
|
作者：
Cheadle, E. J. [1 ]
Sidon, L. [1 ]
Dovedi, S. J. [1 ]
Melis, M. H. [1 ]
Alduaij, W. [1 ]
Illidge, T. M. [1 ]
Honeychurch, J. [1 ]
机构：
[1] Univ Manchester, Inst Canc Sci, Targeted Therapy Grp, Manchester, Lancs, England
来源：
IMMUNOLOGY | 2013年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [31] Anti-CD20 in lupus
    Isenberg, DA
    Leandro, MJ
    Ehrenstein, MR
    Edwards, JCW
    Manson, J
    Cambridge, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 27 - 28
  • [32] Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma
    Heinrich, Daniel A.
    Weinkauf, Marc
    Hutter, Grit
    Zimmermann, Yvonne
    Jurinovic, Vindi
    Hiddemann, Wolfgang
    Dreyling, Martin
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (04) : 606 - 610
  • [33] Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia
    Lauria, F
    Lenoci, M
    Annino, L
    Raspadori, D
    Marotta, G
    Bocchia, M
    Forconi, F
    Gentili, S
    La Manda, M
    Marconcini, S
    Tozzi, M
    Baldini, L
    Zinzani, PL
    Foà, R
    [J]. HAEMATOLOGICA, 2001, 86 (10) : 1046 - 1050
  • [34] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Robak, Tadeusz
    Robak, Ewa
    [J]. BIODRUGS, 2011, 25 (01) : 13 - 25
  • [35] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Tadeusz Robak
    Ewa Robak
    [J]. BioDrugs, 2011, 25 : 13 - 25
  • [36] Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas
    Pagel, JM
    Hedin, N
    Subbiah, K
    Meyer, D
    Mallet, R
    Axworthy, D
    Theodore, LJ
    Wilbur, DS
    Matthews, DC
    Press, OW
    [J]. BLOOD, 2003, 101 (06) : 2340 - 2348
  • [37] B cell depletion by anti-CD20 antibodies entrains trabecular bone loss in mice
    Kolomansky, A.
    Deshet-Unger, N.
    Ostrovsky, A.
    Hiram-Bab, S.
    Ben-Califa, N.
    Liron, T.
    Oster, H. S.
    Mittelman, M.
    Gabet, Y.
    Neumann, D.
    [J]. FEBS JOURNAL, 2017, 284 : 141 - 141
  • [38] Parameters critical for the effector mechanism of anti-CD20 antibodies revisited
    Stasilojc, Grzegorz
    Felberg, Anna
    Okroj, Marcin
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (06) : 777 - 779
  • [39] Treatment of posttransplantation diabetes mellitus with anti-CD20 monoclonal antibodies
    Vandenbosch, K
    Champagne, MA
    Gonthier, M
    Moghrabi, A
    Vachon, MF
    Duval, M
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 64 - 64
  • [40] Anti-CD20 monoclonal antibodies: Beyond B-cells
    Avivi, Irit
    Stroopinsky, Dina
    Katz, Tamar
    [J]. BLOOD REVIEWS, 2013, 27 (05) : 217 - 223
12345